✦ LIBER ✦

Mesulergine (CU32-085) in the treatment of Parkinson's disease

✍ Scribed by Dr Ronald F. Pfeifer; Kathleen Wilken; Carolyn Glaeske

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 251 KB
Volume: 17
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.410170405

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The initial treatment of Parkinson's dis

The initial treatment of Parkinson's disease

✍ Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB 👁 2 views

Viral vectors in the treatment of Parkin

Viral vectors in the treatment of Parkinson's disease

✍ David S. Latchman; Robert S. Coffin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

s disease is an obvious target for the development of gene therapy procedures which could involve both the delivery of the gene encoding tyrosine hydroxylase to boost dopamine production or the delivery of genes encoding neurotrophic factors such as GDNF to promote the survival of dopaminergic neuro

Treatment of drooling in Parkinson's dis

Treatment of drooling in Parkinson's disease with botulinum toxin

✍ Wolfgang H. Jost 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Levodopa in the treatment of Parkinson's

Levodopa in the treatment of Parkinson's disease: A consensus meeting viewpoint

✍ Y. Agid; E. Ahlskog; A. Albanese; D. Calne; T. Chase; J. De Yebenes; S. Factor; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 21 KB 👁 2 views

Quetiapine for the treatment of drug-ind

Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease

✍ Hubert H. Fernandez; Joseph H. Friedman; Carol Jacques; Michael Rosenfeld 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB 👁 1 views

Atypical antipsychotics in the treatment

Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease

✍ Joseph H. Friedman; Stewart A. Factor 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 1 views